Indan Journal of Medical Research Indan Journal of Medical Research Indan Journal of Medical Research Indan Journal of Medical Research
  Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login  
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 51       

   Table of Contents      
CORRESPONDENCE
Year : 2019  |  Volume : 150  |  Issue : 4  |  Page : 417-418

Authors' response


1 Department of Critical Care Medicine, Apollo Hospitals, Bhubaneswar 751 005, Odisha, India
2 Department of Microbiology, Apollo Hospitals, Bhubaneswar 751 005, Odisha, India

Date of Submission28-Aug-2019
Date of Web Publication29-Nov-2019

Correspondence Address:
Sharmili Sinha
Department of Critical Care Medicine, Apollo Hospitals, Bhubaneswar 751 005, Odisha
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0971-5916.272085

Rights and Permissions

How to cite this article:
Sinha S, Sahu S, Pati J, Ray B, Pattnaik SK. Authors' response. Indian J Med Res 2019;150:417-8

How to cite this URL:
Sinha S, Sahu S, Pati J, Ray B, Pattnaik SK. Authors' response. Indian J Med Res [serial online] 2019 [cited 2019 Dec 13];150:417-8. Available from: http://www.ijmr.org.in/text.asp?2019/150/4/417/272085

We thank the author[1] for her interest in our study[2].

  1. The authors have mentioned about the definition of a pandrug-resistant (PDR) isolate as described by Ghafur et al[3]. This implies that the criteria have been followed to brand the organism as a PDR.
  2. It is agreed that the CLSI/EUCAST-approved micro broth dilution remains a challenge till date in routine microbiology laboratories. Hence, this is not being used in our laboratory which is a routine laboratory only. Instead, the available and accessible methods are used. Hence, susceptibility to colistin has been determined by E-strip as well as correlating it with VITEK-2 minimum inhibitory concentration reports. We are aware that both these methods can have major errors. Therefore, it has been stated that colistin susceptibility has to be interpreted with caution and treatment should be done only after judicious clinical assessment. The isolates were judged as pathogen or colonizer by two independent assessors before being actually treated.




 
   References Top

1.
Behara B. Challenges & issues of colistin susceptibility testing in diagnostic microbiology laboratories. Indian J Med Res 2019; 150 : 417-8.  Back to cited text no. 1
    
2.
Sinha S, Sahu S, Pati J, Ray B, Pattnaik SK. Retrospective analysis of colistin-resistant bacteria in a tertiary care centre in India. Indian J Med Res 2019; 149 : 418-22.  Back to cited text no. 2
    
3.
Ghafur A, Vidyalakshmi PR, Murali A, Priyadarshini K, Thirunarayan MA. Emergence of pan-drug resistance amongst Gram-negative bacteria1. The first case series from India. J Microbial Infect Disease 2014; 4 : 86-91.  Back to cited text no. 3
    




 

Top
 
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    References

 Article Access Statistics
    Viewed126    
    Printed0    
    Emailed0    
    PDF Downloaded35    
    Comments [Add]    

Recommend this journal